CD109 and brain neoplasm: Also, the most promising biomarkers for the discrimination between LGG plus GT and PA were TMSB4X and CD109 (Fig. 3A and Supporting Figure S1A), while the most promising biomarkers for the discrimination between EMB MB and all the other brain tumors were 14.3.3 (YWHA-Z,G,E) and HSP90 alpha (Fig. 3B; and Supporting Figure S1B).